Vital KSK Holdings, Inc. (3151.T)
JPY 1276.0
(0.87%)
JPY 1276.0
(0.87%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 8.84 Billion JPY | 0.59% |
| 2022 | 5.82 Billion JPY | -2.92% |
| 2021 | 6.07 Billion JPY | 127.83% |
| 2020 | 939 Million JPY | -61.69% |
| 2019 | 7.21 Billion JPY | 3.49% |
| 2018 | 11.54 Billion JPY | 11.1% |
| 2017 | 9.77 Billion JPY | -6.5% |
| 2016 | 10.28 Billion JPY | -26.78% |
| 2015 | 13.5 Billion JPY | 59.75% |
| 2014 | 9.29 Billion JPY | 1.1% |
| 2013 | 9.19 Billion JPY | 4.59% |
| 2012 | 8.51 Billion JPY | 24.58% |
| 2011 | 7.74 Billion JPY | 64.1% |
| 2010 | 308 Million JPY | -38.15% |
| 2009 | 6.61 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 2.1 Billion JPY | 24.34% |
| 2024 Q1 | 2.07 Billion JPY | 21.17% |
| 2023 Q1 | 1.49 Billion JPY | 40.36% |
| 2023 Q4 | 901 Million JPY | -70.49% |
| 2023 Q3 | 3.05 Billion JPY | 50.02% |
| 2023 FY | - JPY | 0.59% |
| 2023 Q2 | 2.03 Billion JPY | 36.39% |
| 2022 FY | - JPY | -2.92% |
| 2022 Q4 | 1.06 Billion JPY | -44.08% |
| 2022 Q3 | 1.9 Billion JPY | 52.08% |
| 2022 Q1 | 1.22 Billion JPY | -25.38% |
| 2022 Q2 | 1.25 Billion JPY | 2.21% |
| 2021 Q4 | 1.63 Billion JPY | -13.28% |
| 2021 Q1 | 1.09 Billion JPY | 552.69% |
| 2021 Q2 | 1.31 Billion JPY | 20.37% |
| 2021 Q3 | 1.89 Billion JPY | 44.05% |
| 2021 FY | - JPY | 127.83% |
| 2020 FY | - JPY | -61.69% |
| 2020 Q4 | 167 Million JPY | 20.14% |
| 2020 Q2 | 679 Million JPY | 424.88% |
| 2020 Q1 | -209 Million JPY | -116.56% |
| 2020 Q3 | 139 Million JPY | -79.53% |
| 2019 Q3 | 2.4 Billion JPY | 43.21% |
| 2019 Q4 | 1.26 Billion JPY | -47.48% |
| 2019 FY | - JPY | 3.49% |
| 2019 Q2 | 1.67 Billion JPY | 22.3% |
| 2019 Q1 | 1.37 Billion JPY | 15.2% |
| 2018 FY | - JPY | 11.1% |
| 2018 Q4 | 1.19 Billion JPY | -47.14% |
| 2018 Q1 | 1.32 Billion JPY | -21.91% |
| 2018 Q2 | 1.47 Billion JPY | 11.88% |
| 2018 Q3 | 2.25 Billion JPY | 52.33% |
| 2017 Q3 | 1.99 Billion JPY | 127.48% |
| 2017 Q4 | 1.69 Billion JPY | -15.14% |
| 2017 FY | - JPY | -6.5% |
| 2017 Q1 | 1.22 Billion JPY | -2.55% |
| 2017 Q2 | 877 Million JPY | -28.17% |
| 2016 Q1 | 2.2 Billion JPY | -35.07% |
| 2016 Q4 | 1.25 Billion JPY | -35.21% |
| 2016 FY | - JPY | -26.78% |
| 2016 Q2 | 901 Million JPY | -59.1% |
| 2016 Q3 | 1.93 Billion JPY | 114.65% |
| 2015 FY | - JPY | 59.75% |
| 2015 Q1 | 1.12 Billion JPY | 107.75% |
| 2015 Q4 | 3.39 Billion JPY | -14.9% |
| 2015 Q3 | 3.98 Billion JPY | 188.29% |
| 2015 Q2 | 1.38 Billion JPY | 22.82% |
| 2014 Q3 | 2 Billion JPY | 315.35% |
| 2014 Q4 | 542 Million JPY | -72.93% |
| 2014 FY | - JPY | 1.1% |
| 2014 Q1 | 2.4 Billion JPY | 119.0% |
| 2014 Q2 | 482 Million JPY | -79.99% |
| 2013 Q3 | 2.27 Billion JPY | 93.13% |
| 2013 Q4 | 1.1 Billion JPY | -51.69% |
| 2013 FY | - JPY | 4.59% |
| 2013 Q1 | 1.38 Billion JPY | 55.93% |
| 2013 Q2 | 1.17 Billion JPY | -14.57% |
| 2012 FY | - JPY | 24.58% |
| 2012 Q3 | 1.05 Billion JPY | -28.93% |
| 2012 Q2 | 1.49 Billion JPY | -27.88% |
| 2012 Q4 | 885 Million JPY | -16.43% |
| 2012 Q1 | 2.06 Billion JPY | -11.78% |
| 2011 Q1 | 884 Million JPY | 262.5% |
| 2011 Q4 | 2.34 Billion JPY | 27.49% |
| 2011 FY | - JPY | 64.1% |
| 2011 Q2 | 1.19 Billion JPY | 35.63% |
| 2011 Q3 | 1.83 Billion JPY | 53.21% |
| 2010 Q4 | -544 Million JPY | -161.26% |
| 2010 FY | - JPY | -38.15% |
| 2010 Q1 | 2.08 Billion JPY | 78.36% |
| 2010 Q3 | 888 Million JPY | -35.61% |
| 2010 Q2 | 1.37 Billion JPY | -33.86% |
| 2009 Q3 | 2.15 Billion JPY | 95.55% |
| 2009 Q1 | 1.75 Billion JPY | 0.0% |
| 2009 Q2 | 1.1 Billion JPY | -37.3% |
| 2009 FY | - JPY | 0.0% |
| 2009 Q4 | 1.16 Billion JPY | -45.7% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| OLBA HEALTHCARE HOLDINGS, Inc. | 2.79 Billion JPY | -216.742% |
| Alfresa Holdings Corporation | 51.97 Billion JPY | 82.988% |
| WIN-Partners Co., Ltd. | 2.91 Billion JPY | -203.221% |
| MediPal Holdings Corporation | 65.31 Billion JPY | 86.462% |
| AS ONE Corporation | 12.65 Billion JPY | 30.129% |
| Yamashita Health Care Holdings,Inc. | 1.23 Billion JPY | -615.951% |
| Suzuken Co., Ltd. | 51.57 Billion JPY | 82.857% |